Skip to content
Home/Companies/Biotech/mbiomics
MB

mbiomics

Biotech·Germany·Active·3yr hold

mbiomics is a biotech company, headquartered in Germany.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns mbiomics?

mbiomics is currently owned by MIG Capital through MIG Fonds 16 (2019 vintage), since 2023.

Hand-verified · updated 2026-07-03

MIG Capital
Investor
MIG Capital
MIG Fonds 16 · 2019 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from MIG Fonds 16

Other portfolio companies in the same fund.

Inbolt
Active
Deep TechFrance· 2022
iOmx Therapeutics
Active
BiotechGermany· 2021
Mimi Hearing Technologies
Active
IndustrialsGermany· 2021
Zadient Technologies
Active
Deep TechFrance· 2021
Innatera
Active
Deep TechNetherlands· 2020
NeraCare
Active
MedTechGermany· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings